State of Alaska Department of Revenue’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.77M | Sell |
14,213
-218
| -2% | -$45.2K | 0.03% | 525 |
|
|
2026
Q1 | $3.24M | Sell |
14,431
-50
| -0.3% | -$12.5K | 0.04% | 475 |
|
|
2025
Q4 | $3.49M | Sell |
14,481
-1,215
| -8% | -$311K | 0.04% | 438 |
|
|
2025
Q3 | $4.3M | Sell |
15,696
-773
| -5% | -$211K | 0.04% | 393 |
|
|
2025
Q2 | $4.25M | Sell |
16,469
-740
| -4% | -$177K | 0.05% | 391 |
|
|
2025
Q1 | $3.85M | Buy |
17,209
+470
| +3% | +$110K | 0.04% | 398 |
|
|
2024
Q4 | $3.83M | Sell |
16,739
-4,011
| -19% | -$966K | 0.04% | 400 |
|
|
2024
Q3 | $5.07M | Sell |
20,750
-3,305
| -14% | -$739K | 0.05% | 348 |
|
|
2024
Q2 | $4.6M | Sell |
24,055
-4,585
| -16% | -$930K | 0.05% | 385 |
|
|
2024
Q1 | $5.67M | Sell |
28,640
-4,010
| -12% | -$735K | 0.06% | 322 |
|
|
2023
Q4 | $5.62M | Sell |
32,650
-8,430
| -21% | -$1.3M | 0.07% | 325 |
|
|
2023
Q3 | $6.07M | Sell |
41,080
-645
| -2% | -$117K | 0.08% | 284 |
|
|
2023
Q2 | $9.12M | Sell |
41,725
-4,447
| -10% | -$991K | 0.11% | 192 |
|
|
2023
Q1 | $10.1M | Sell |
46,172
-24
| -0.1% | -$5.21K | 0.12% | 183 |
|
|
2022
Q4 | $9.61M | Sell |
46,196
-1,820
| -4% | -$400K | 0.12% | 195 |
|
|
2022
Q3 | $10.5M | Sell |
48,016
-4,895
| -9% | -$1.11M | 0.14% | 147 |
|
|
2022
Q2 | $11.1M | Buy |
52,911
+9,540
| +22% | +$2.03M | 0.14% | 154 |
|
|
2022
Q1 | $10.5M | Sell |
43,371
-3,235
| -7% | -$782K | 0.11% | 190 |
|
|
2021
Q4 | $12.1M | Sell |
46,606
-6,975
| -13% | -$1.81M | 0.12% | 182 |
|
|
2021
Q3 | $14.1M | Sell |
53,581
-1,162
| -2% | -$318K | 0.14% | 147 |
|
|
2021
Q2 | $13.5M | Sell |
54,743
-15,089
| -22% | -$3.17M | 0.14% | 164 |
|
|
2021
Q1 | $13.5M | Sell |
69,832
-4,954
| -7% | -$993K | 0.15% | 159 |
|
|
2020
Q4 | $15.9M | Sell |
74,786
-7,570
| -9% | -$1.51M | 0.18% | 118 |
|
|
2020
Q3 | $14.1M | Buy |
82,356
+31,747
| +63% | +$5.86M | 0.17% | 126 |
|
|
2020
Q2 | $9.72M | Sell |
50,609
-6,526
| -11% | -$1.07M | 0.12% | 206 |
|
|
2020
Q1 | $8.41M | Buy |
57,135
+4,085
| +8% | +$651K | 0.13% | 201 |
|
|
2019
Q4 | $8.22M | Buy |
53,050
+14,849
| +39% | +$2.14M | 0.11% | 267 |
|
|
2019
Q3 | $5.16M | Buy |
38,201
+12,566
| +49% | +$1.65M | 0.07% | 370 |
|
|
2019
Q2 | $3.13M | Sell |
25,635
-8,265
| -24% | -$916K | 0.05% | 414 |
|
|
2019
Q1 | $3.52M | Sell |
33,900
-369
| -1% | -$38.1K | 0.06% | 356 |
|
|
2018
Q4 | $3.9M | Sell |
34,269
-3,652
| -10% | -$391K | 0.08% | 287 |
|
|
2018
Q3 | $4.37M | Sell |
37,921
-1,138
| -3% | -$125K | 0.07% | 307 |
|
|
2018
Q2 | $4.04M | Buy |
39,059
+4,220
| +12% | +$427K | 0.07% | 311 |
|
|
2018
Q1 | $3.43M | Buy |
34,839
+3,500
| +11% | +$331K | 0.07% | 325 |
|
|
2017
Q4 | $2.65M | Buy |
31,339
+10,300
| +49% | +$851K | 0.06% | 365 |
|
|
2017
Q3 | $1.62M | Buy |
21,039
+11,510
| +121% | +$880K | 0.08% | 257 |
|
|
2017
Q2 | $742K | Buy |
9,529
+590
| +7% | +$42.2K | 0.05% | 302 |
|
|
2017
Q1 | $643K | Buy |
+8,939
| New | +$618K | 0.05% | 310 |
|
Other funds holding RMD
State of Alaska Department of Revenue's RMD Position: Q2 2026 in Review
State of Alaska Department of Revenue reduced its ResMed (RMD) stake by 1.5% in Q2 2026, selling an estimated $45.2K and leaving 14,213 shares worth $2.77M. The position accounts for 0.03% of the portfolio, ranked #525.
State of Alaska Department of Revenue first reported a position in RMD in Q1 2017 and has held it in 38 quarters since. The position peaked at $15.9M in Q4 2020. 609 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- State of Alaska Department of Revenue held 14,213 shares of ResMed worth $2.77M as of Q2 2026.
- State of Alaska Department of Revenue sold 218 ResMed shares in Q2 2026, an estimated $45.2K.
- ResMed made up 0.03% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #525 holding.
- State of Alaska Department of Revenue first reported a position in ResMed in Q1 2017 and has held it in 38 quarters since.
- State of Alaska Department of Revenue's ResMed position peaked at $15.9M in Q4 2020.
- 609 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.